Clinical Trials in Texas

Showing 12321-12340 of 15,101 trials

Safety Study for the Treatment of Abdominal Aortic Aneurysms

NCT00610090

The primary study objective, at this time, is to follow out to 5 years post implant the safety of already enrolled subjects who were treated with the UniFit Aorto-uni-iliac (AUI) Endoluminal Stent Graft (the "study device") for the repair of abdominal aortic aneurysms (AAAs).

Abdominal Aortic Aneurysms

Duke Vascular, Inc.71 participantsStarted May 2007

Loma Linda, California, United States • Torrance, California, United States • Newark, Delaware, United States +16 more locations

COMPLETEDPhase 355 miles

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

NCT01807923

The primary objective of the study was to evaluate the efficacy of lumacaftor in combination with ivacaftor at Week 24 in participants aged 12 years and older with cystic fibrosis (CF) who are homozygous for the F508del mutation on the CF transmembrane conductance regulator (CFTR) gene.

Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

Vertex Pharmaceuticals Incorporated559 participantsStarted May 2013

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Tucson, Arizona, United States +86 more locations

Safety Study for the Treatment of Abdominal Aortic Aneurysms

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

Find Trials by Condition in Texas

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

Phase III Study in Refractory Behcet's Disease

Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis

Effect of Febuxostat on Blood Pressure

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Gadobutrol Enhanced MRA of the Renal Arteries

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Surgical Reduction of the Inferior Turbinates for Nasal Obstruction